The customer, a syncardia certified hospital, reported that the patient died on (b)(6) 2019.The customer also reported the patient had elevated liver enzymes and lactate, and had complained of abdominal pain.The results of a subsequent exploratory laparotomy indicated there was no evidence of ischemia, but his gallbladder was removed.The patient's state did not improve after this procedure and he remained acidotic.The customer also reported the patient exhibited clinical depression associated with passive suicidal ideation.Per the patient's and the family's wishes, the decision was made to turn off the tah-t after 12 days of support.The customer listed the cause of death as hepatorenal failure with additional comments/observations of necrotic liver and sepsis and that the tah-t did not cause or contribute to the patient death.The customer also reported that the tah-t was explanted and that no autopsy was performed.No further information has been provided at this time.
|
The customer did not report a device malfunction and attributed the cause of death to hepatorenal failure with necrotic liver and sepsis.The tah-t was explanted following the autopsy and returned to syncardia for evaluation.Visual inspection, valve evaluation, thrombus formation evaluation, and a stroke volume evaluation were performed during the tah-t explant analysis.No anomalies or abnormalities were observed.This issue will continue to be monitored and trended as part of the customer experience process.Syncardia has completed its evaluation of this complaint and is closing this file.(b)(4) follow-up report 1.
|